Option Care Health, Inc. Q2 2025 Earnings Recap

OPCH Q2 2025 July 30, 2025

Get alerts when OPCH reports next quarter

Option Care Health delivered a robust second quarter, achieving a 15% year-over-year revenue growth, leading to an upward revision of revenue, adjusted EBITDA, and adjusted EPS guidance for the year.

Earnings Per Share Beat

$0.41 vs $0.40 est.

+2.5% surprise

Revenue Beat

1416085000 vs 1402623300 est.

+1.0% surprise

Market Reaction

1-Day -4.21%

5-Day -8.91%

30-Day -6.4%

See OPCH alongside your other holdings

Add to your portfolio — free

Key Takeaways

Revenue increased 15% year-over-year, driven by strong performance in both acute and chronic therapy segments.
Adjusted EBITDA grew by 5% despite headwinds, underscoring operational efficiency and disciplined spending.
Generated over $90 million in cash flow from operations, positioning the company for ongoing capital deployment and shareholder value initiatives.
Successful partnerships with health plans and pharma manufacturers enhance access to tailored therapies, supporting growth in rare and orphan drugs.
Executed $50 million in share repurchases during the quarter, reflecting confidence in long-term business potential and shareholder value creation.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit OPCH on AllInvestView.

Next Q3 2025